- Novavax again delays its timeline for ramping up COVID-19 vaccine production and seeking regulatory authorization
- Non-hospitalised COVID-19 patients have a low risk of serious long-term effects, a study published in The Lancet journal shows
- The WHO classifies the India variant as a global concern, with some preliminary studies showing that it spreads more easily
- Is the B.1.617 variant to blame for the unexpected surge in India cases? Scientists are investigating
United StatesU.S. children ages 12 to 15 could begin COVID-19 vaccinations Thursday
EnergyU.S. fuel supplies tighten as energy pipeline outage enters fifth day
Autos & TransportationEXCLUSIVE Tesla puts brake on Shanghai land buy as U.S.-China tensions weigh - sources
United KingdomQueen Elizabeth to set out UK government's post-pandemic agenda
ChinaChina demographic crisis looms as population growth slips to slowest ever
TechnologyEXCLUSIVE Foxconn’s iPhone output in India down amid COVID surge-sources
Latest Stories
Talking Points
Blue-chip employers with the lowest worker wages raised CEO pay during the pandemic … This NASA spacecraft collecting asteroid samples will take two years to return to Earth … NBC drops 2022 Golden Globes ceremony after a backlash over lack of diversity in the HFPA